# Cambrian BioPharma Inc — Form D

Cambrian BioPharma Inc of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-02. The offering totals $100.8M, of which $92.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-12-02
- Form: D
- Accession: 0000897069-21-000581
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $100.8M
- Amount sold: $92.2M
- Remaining: $8.6M
- Investors: 56
- Date of first sale: 2021-10-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-423260

## Issuer

- Name: Cambrian BioPharma Inc
- CIK: 0001797409
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 228 Park Avenue South Suite 66643, NEW YORK, NY, 10003
- Phone: (516) 962-3186

## Officers, directors & promoters (19)

| Name | Role | Location |
| --- | --- | --- |
| James G Peyer | Promoter | New York, NY |
| Maryanna Saenko | Related Person | Los Altos, CA |
| James Peyer | Related Person | New York, NY |
| Juliette Han | Related Person | New York, NY |
| Christian G Angermayer | Director | New York, NY |
| Maryanna G Saenko | Director | New York, NY |
| Paul G Farr | Director | New York, NY |
| James G Peyer | Director | New York, NY |
| James G Peyer | Executive Officer | New York, NY |
| Brenton G Saunders | Director | New York, NY |
| Paul Farr | Related Person | Santa Monica, CA |
| Mark Nuttall | Related Person | New York, NY |
| Christian G Angermeyer | Director | New York, NY |
| Ruth Thieroff-Ekerdt | Related Person | New York, NY |
| William DeVaul | Related Person | New York, NY |
| Christian Angermeyer | Related Person | Birkirkara, O1 |
| Brenton L. Saunders | Related Person | Bridgewater, NJ |
| Martin Gunhaga | Related Person | Umea, V7 |
| Lorin Van Nuland | Related Person | Birkirkara, O1 |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-07-15](https://search.stillhousedata.com/formd/0000950172-26-000183) | D | $129.8M | $123.8M |
| [2025-01-13](https://search.stillhousedata.com/formd/0000897069-25-000101) | D/A | $37.6M | $23.0M |
| [2023-12-22](https://search.stillhousedata.com/formd/0000897069-23-001843) | D | $40.0M | $7.7M |
| [2021-05-06](https://search.stillhousedata.com/formd/0000897069-21-000216) | D | $28.4M | $28.4M |
| [2020-01-27](https://search.stillhousedata.com/formd/0000897069-20-000054) | D | $4.8M | $4.8M |

## More

- [CIK 1797409 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1797409&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000897069-21-000581.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.